申请人:Università degli Studi di Siena
公开号:EP3290412A1
公开(公告)日:2018-03-07
The present invention discloses novel anti-HIV agents targeting the HIV Nucleocapsid protein (NC), which is one of the most conserved sequences within HIV strains and is highly required for HIV replication. The compounds of the invention are particularly useful to overcome antiretroviral drug-resistance in HIV-1 infected individuals.
本发明揭示了针对HIV核壳蛋白(NC)的新型抗HIV药物,该蛋白是HIV菌株中最保守的序列之一,对HIV复制非常重要。本发明的化合物特别适用于克服HIV-1感染个体中的抗逆转录病毒药物耐药性。